-+ 0.00%
-+ 0.00%
-+ 0.00%

Eloxx Pharma Q3 EPS $(0.49) Beats $(0.58) Estimate

Benzinga·11/16/2026 11:55:48
Listen to the news
Eloxx Pharma (NASDAQ:ELOX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.58) by 15.52 percent. This is a 15.52 percent increase over losses of $(0.58) per share from the same period last year.